TrialThe Journal of clinical investigation2020
Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity.
Alana E O'Mara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
231 papers cite itlatest 60 shown
this paperpooled ittrialcites it